$235 Million is the total value of Mass General Brigham, Inc's 55 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
JNCE | New | JOUNCE THERAPEUTICS INC | $1,000 | – | 20,957 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-04-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES CORE U.S. AGGREGATE ETF | 10 | Q1 2021 | 100.0% |
COINBASE GLOBAL INC CLASS A | 10 | Q3 2023 | 89.8% |
ISHARES CORE SP 500 ETF | 9 | Q2 2023 | 57.8% |
ISHARES CORE U.S. AGGREGATE ETF | 9 | Q2 2023 | 40.5% |
ISHARES MSCI ACWI ETF | 8 | Q1 2021 | 100.0% |
ISHARES CORE SP 500 ETF | 7 | Q1 2021 | 100.0% |
RIVIAN AUTOMOTIVE INC | 3 | Q3 2023 | 10.2% |
REVOLUTION MEDICINES INC | 2 | Q1 2023 | 5.7% |
PINDUODUO INC ADR | 2 | Q3 2021 | 1.1% |
JOUNCE THERAPEUTICS INC | 2 | Q1 2022 | 0.0% |
View Mass General Brigham, Inc's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-04 |
13F-HR | 2024-01-24 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-05 |
13F-HR | 2023-01-19 |
13F-HR | 2022-10-19 |
13F-HR | 2022-07-27 |
13F-HR | 2022-04-15 |
13F-HR | 2022-01-19 |
View Mass General Brigham, Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.